• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure.

作者信息

Liu Tsung-Hao, Hsu Chih-Hung, Shao Yu-Yun

机构信息

Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.

Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Liver Cancer. 2018 May;7(2):205-208. doi: 10.1159/000486763. Epub 2018 Apr 20.

DOI:10.1159/000486763
PMID:29888209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5985408/
Abstract
摘要

相似文献

1
Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure.晚期肝细胞癌合并即将发生肝衰竭患者肝动脉化疗灌注成功案例
Liver Cancer. 2018 May;7(2):205-208. doi: 10.1159/000486763. Epub 2018 Apr 20.
2
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial.索拉非尼联合低剂量顺铂和氟尿嘧啶肝动脉灌注化疗与索拉非尼单药治疗晚期肝细胞癌的随机、开放标签、3 期试验（SILIUS）
Lancet Gastroenterol Hepatol. 2018 Jun;3(6):424-432. doi: 10.1016/S2468-1253(18)30078-5. Epub 2018 Apr 7.
3
Proposal of selection criteria for operative resection of hepatocellular carcinoma with inferior vena cava tumor thrombus incorporating hepatic arterial infusion chemotherapy.纳入肝动脉灌注化疗的伴有下腔静脉瘤栓的肝细胞癌手术切除选择标准的建议
Surgery. 2017 Oct;162(4):742-751. doi: 10.1016/j.surg.2017.05.011. Epub 2017 Jul 10.
4
[Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports].[经动脉联合（5-氟尿嘧啶、阿霉素和顺铂）灌注化疗成功治疗伴有多发肝内转移和/或门静脉血栓形成的晚期肝细胞癌——两例报告]
Gan To Kagaku Ryoho. 2005 Oct;32(11):1842-5.
5
Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.晚期肝细胞癌的介入放射学治疗：肝动脉灌注化疗与经导管动脉碘油化疗栓塞术的比较
AJR Am J Roentgenol. 2003 Nov;181(5):1327-34. doi: 10.2214/ajr.181.5.1811327.
6
A long-term survival case underwent repeated hepatic arterial infusion chemotherapy with portal branch ligation and wrapping of the liver using sheets for hepatocellular carcinoma.
Hepatogastroenterology. 2002 Sep-Oct;49(47):1423-4.
7
Hepatic intra-arterial cetuximab in combination with 5-fluorouracil and cisplatin as salvage treatment for sorafenib-refractory hepatocellular carcinoma.肝动脉内西妥昔单抗联合氟尿嘧啶和顺铂作为索拉非尼耐药的肝细胞癌的挽救治疗。
Anticancer Res. 2011 Nov;31(11):3927-33.
8
[Three cases of hepatocellular carcinoma, over 3 cm in diameter, with liver cirrhosis treated with combination of radiofrequency ablation and continuous hepatic arterial infusion chemotherapy].[三例直径超过3厘米的肝细胞癌合并肝硬化患者采用射频消融联合肝动脉持续灌注化疗治疗]
Gan To Kagaku Ryoho. 2007 Jul;34(7):1123-6.
9
Efficacy of iron chelator deferoxamine for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma patients refractory to current treatments.铁螯合剂去铁胺对当前治疗无效的晚期肝细胞癌患者肝动脉灌注化疗的疗效。
Hepatol Int. 2014 Sep;8 Suppl 2:492-8. doi: 10.1007/s12072-013-9515-3. Epub 2014 Jan 29.
10
Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma.奥沙利铂联合氟尿嘧啶/亚叶酸肝动脉灌注化疗对比索拉非尼治疗晚期肝细胞癌
J Hepatol. 2018 Jul;69(1):60-69. doi: 10.1016/j.jhep.2018.02.008. Epub 2018 Feb 20.

引用本文的文献

1
Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma.重新审视肝动脉灌注化疗治疗晚期肝细胞癌。
Int J Mol Sci. 2021 Nov 28;22(23):12880. doi: 10.3390/ijms222312880.
2
Hepatic Arterial Infusion Chemotherapy: A Potential Therapeutic Option for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.肝动脉灌注化疗：门静脉癌栓型肝细胞癌的一种潜在治疗选择
Liver Cancer. 2018 May;7(2):209-210. doi: 10.1159/000488156. Epub 2018 Apr 20.

本文引用的文献

1
Sorafenib versus Hepatic Arterial Infusion Chemotherapy as Initial Treatment for Hepatocellular Carcinoma with Advanced Portal Vein Tumor Thrombosis.索拉非尼与肝动脉灌注化疗作为晚期门静脉肿瘤血栓形成的肝细胞癌初始治疗的比较
Liver Cancer. 2017 Nov;6(4):275-286. doi: 10.1159/000473887. Epub 2017 Aug 29.
2
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.纳武利尤单抗治疗晚期肝细胞癌患者（CheckMate 040）：一项开放标签、非对照、1/2 期剂量递增和扩展试验。
Lancet. 2017 Jun 24;389(10088):2492-2502. doi: 10.1016/S0140-6736(17)31046-2. Epub 2017 Apr 20.
3
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study.在 Child-Pugh 亚组中观察索拉非尼在临床实践中的应用：GIDEON 研究。
J Hepatol. 2016 Dec;65(6):1140-1147. doi: 10.1016/j.jhep.2016.07.020. Epub 2016 Jul 25.
4
Hepatocellular carcinoma in Child-Pugh C cirrhosis: prognostic factors and survival benefit of nontransplant treatments.肝硬化 Child-Pugh C 级患者中的肝细胞癌：非移植治疗的预后因素和生存获益。
Dig Dis. 2013;31(5-6):490-8. doi: 10.1159/000355259. Epub 2013 Nov 21.
5
Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan.日本全国原发性肝癌调查中氟尿嘧啶和顺铂肝动脉灌注化疗治疗晚期肝细胞癌的效果。
Br J Cancer. 2013 Oct 1;109(7):1904-7. doi: 10.1038/bjc.2013.542. Epub 2013 Sep 5.
6
A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy.一项针对接受过抗血管生成治疗后失败的晚期肝细胞癌患者进行肝动脉灌注化疗的初步研究。
Liver Int. 2013 Oct;33(9):1413-9. doi: 10.1111/liv.12207. Epub 2013 May 28.
7
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma according to Child-Pugh classification.根据 Child-Pugh 分级的晚期肝细胞癌肝动脉灌注化疗。
J Gastroenterol Hepatol. 2012 Dec;27(12):1850-7. doi: 10.1111/j.1440-1746.2012.07276.x.